Non-reactive anti-HBs titers (<10 mIU/mL) were present in 46%

of vaccinated subjects and in all of the unvaccinated participants. A non-reactive anti-HBs titer was significantly associated with non-vaccination (p < 0.0001; OR 22.28; 95% CI 2.92–170.12), vaccine receipt between birth and 5 years of age, and receiving only 1 or 2 doses of the HBV vaccine ( Table check details 3). Older adults were more likely to have been vaccinated between the ages of 6 and 18 years and were more likely to have unsafe sexual risk factor (Table 4A). Receiving only 1 or 2 doses of the HBV vaccine was associated with having piercings or tattoos (Table 4B). Those men who received the HBV vaccine between the ages of 6 and 18 were more likely to have an incomplete vaccination Sirolimus cell line schedule (p < 0.001; OR 5.13; 95% CI 2.05–12.84). Young men without a VC were more likely to be less educated, to be employed, to have less educated parents, and to have a lower household income (data not shown). In addition, adults without VCs were more likely to have undetectable anti-HBs titers (p < 0.0001; OR 2.51; 95% CI 1.64–3.82). Overall, 70% of the studied adults had been vaccinated and/or had

positive anti-HBs titers. Since the hepatitis B vaccine was included in the Brazilian National Immunization Program, there has been a substantial increase in vaccination coverage, especially among children and adolescents [3]. However, cases of hepatitis B have not appeared to decrease accordingly, probably due to long incubation and latency periods, the misdiagnosis of acute cases, and underreporting of disease [10]. Mandatory screening has reduced the transmission of HBV through blood transfusions, but sexual transmission remains a concern among unvaccinated adolescents and adults. This raises questions regarding the need to promote L-NAME HCl vaccination through educational campaigns, whether the vaccination strategy has been adequate, and whether vaccination coverage is high

enough to decrease the occurrence of disease [3]. This vaccination coverage analysis showed a lower rate of vaccination than the current estimates, which suggest that 75% of the population younger than 20 years old in Brazil has been vaccinated [10]. Considering the vaccination coverage of subjects in this study and the anti-HBs detectable titers, the actual vaccination coverage in this population may vary between 57 and 70%. Nevertheless, this coverage is quite low considering that the current hepatitis B vaccination strategy should guarantee the vaccination of all individuals up to age 20. Approximately 2/3 of all individuals with proven vaccination history received the last dose of the vaccine during the first five years of life. Higher dropout rates among subjects vaccinated at older ages reinforce the importance of vaccinating children after birth, the best way of guaranteeing completion of the 3-dose schedule.